CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Shanghai Ming Ju Biotechnology Co., Ltd.
Wuhan Ammunition Life-tech Co., Ltd
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Beijng Immunoah Pharma Tech Co., Ltd.
Humanitas Clinical and Research Center
Peter MacCallum Cancer Centre, Australia
Haukeland University Hospital
Aurigene Discovery Technologies Limited
Tongji Hospital
Guangxi Medical University
Chongqing Precision Biotech Co., Ltd
Gruppo Italiano Malattie EMatologiche dell'Adulto
Peking University Third Hospital
St. Petersburg State Pavlov Medical University
Assistance Publique - Hôpitaux de Paris
University of Kansas Medical Center
Shanghai Ming Ju Biotechnology Co., Ltd.
Nanfang Hospital, Southern Medical University
National Cancer Institute, Naples
South Valley University
KK Women's and Children's Hospital
Vitadx
BeBetter Med Inc
Nanfang Hospital, Southern Medical University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Guangdong Second Provincial General Hospital
Chongqing University Cancer Hospital
Maastricht University Medical Center
Maastricht University Medical Center
China Medical University Hospital
Cantonal Hospital of St. Gallen
University of Milano Bicocca
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Azienda Ospedaliera Universitaria Integrata Verona
The First Affiliated Hospital of Soochow University
Zhongnan Hospital
Telios Pharma, Inc.
Shanghai Zhongshan Hospital
Great Ormond Street Hospital for Children NHS Foundation Trust
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Qilu Pharmaceutical Co., Ltd.
Imperial College London
BGI, China
Cambridge University Hospitals NHS Foundation Trust
University of Bologna
Athenex, Inc.
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Chinese PLA General Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.